RPS Hybrid Satellite Meeting – USCAP 2023
Update on Monoclonal Gammopathy of Renal Significance
Chairs: Mei Lin Bissonnette and Benjamin Adam
DATE AND VENUE:
Sunday, March 12, 2023 (Central Daylight Time)
12:00 - 1:00 pm: Box lunch pick up (in-person only)
1:00 - 4:00 pm: Program (in-person and online)
Note: Daylight saving time starts March 12
- - - - - - - - - - - - - - - - -
In-person: The Sheraton New Orleans Hotel
500 Canal St.
New Orleans, LA 70130
Less than 1 mile from the Ernest N. Morial Convention Center
In-person attendance registration available until February 26th, 2023.
- - - - - - - - - - - - - - - - -
Online: Livestream with live Q&A
Link will be sent to registered individuals
Online attendance registration available until March 12th
Second registration for Zoom access is required. Link for Zoom registration will be sent after initial meeting registration
|
Recording of the satellite meeting will be available online to all registered participants (in-person and online) after the meeting
|
- - - - - - - - - - - - - - - - -
REGISTRATION FEES:
All registration fees are in USD
|
In-person
|
Online
|
|
Regular member
|
95.00
|
75.00
|
|
Junior member
|
65.00
|
45.00
|
|
Non-member/onsite registration
|
125.00
|
110.00
|
|
Time
|
Topic
|
Speaker
|
| 12:00 pm |
Pick up lunch box (in-person) |
|
|
1:00-1:30 pm
|
Update on PGNMID
|
Samih Nasr
Mayo Clinic
Rochester, MN
|
|
1:30-2:00 pm
|
IgA with monoclonal deposits
|
Ian Roberts
John Radcliffe Hospital
Oxford, UK
|
|
2:00-2:30 pm
|
Monoclonal fibrillary GN
|
Nicole Andeen
OHSU
Portland, OR
|
|
2:30-3:00 pm
|
Coffee Break
|
|
|
3:00-3:30 pm
|
Monoclonal immunoglobulin in the intersitium
|
Virginie Royal
University of Montreal
Montreal, Canada
|
|
3:30-4:00 pm
|
MGRS: a clinical perspective
|
Christopher Venner
BC Cancer Agency
Vancouver, Canada
|
Learning Objectives:
- Describe the clinicopathologic characteristics, diagnosis, and potential pathogenesis for proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID)
- Understand the causes and approach to diagnosis of glomerular IgA deposits with light chain restriction
- Discuss current knowledge and challenges in monotypic fibrillary glomerulonephritis
- Name the different tubulointerstitial kidney lesions identified on the kidney biopsy from patients with monoclonal gammopathy
- Appreciate the most relevant components of a renal biopsy report from the perspective of a hematologist
Joint Providership Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the College of American Pathologists and the Renal Pathology Society. The College of American Pathologists is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement:
The College of American Pathologists designates this live (or internet live) educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Disclaimer:
The content of this accredited CE (CME) activity does not necessarily reflect the view or policies of the College of American Pathologists.
Disclosure Information
Below you will find the financial disclosure relationships for anyone who was able to affect the content of this educational activity.
The CAP mitigates all the relevant financial relationships listed for these individuals.
The following speakers/planners have no financial relationships to disclose:
Planners: Mei Lin Bissonnette (University of British Columbia), Benjamin Adam (University of Alberta)
Faculty: Samih Nasr (Mayo Clinic), Nicole Andeen (Oregon Health & Science University)
The following speakers/planners have the following financial relationships to disclose:
|
Name, credentials of planner/speaker
|
Name of Ineligible company
|
For what role
|
|
Virginie Royal, MD
|
Vertex Pharmaceutical
|
Consultant
|
|
Virginie Royal, MD
|
Janssen
|
Speaker
|
|
Ian Roberts, MD
|
Novartis
|
Consultant
|
|
Ian Roberts, MD
|
Travere
|
Consultant
|
|
Ian Roberts, MD
|
Q32 Bio
|
Consultant
|
|
Christopher Venner, MD
|
Janssen
|
Consultant
|
|
Christopher Venner, MD
|
BMS
|
Consultant
|
|
Christopher Venner, MD
|
Pfizer
|
Consultant
|
|
Christopher Venner, MD
|
Sanofi
|
Consultant
|
|
Christopher Venner, MD
|
FORUS
|
Consultant
|
|
Christopher Venner, MD
|
Takeda
|
Consultant
|
|
Christopher Venner, MD
|
Abbvie
|
Consultant
|
|
Christopher Venner, MD
|
GSK
|
Consultant
|
The following In-Kind Support has been received for this activity:
None
The following Commercial Support has been received for this activity:
None
The Sheraton New Orleans Hotel
